Novartis AG
151.12USD
-5.1500 (-3.30%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on NVS.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $2.24▲ | $2.2 | 1 | 0 |
| Next quarter | $2.22▼ | $2.32 | 1 | 0 |
| Current year | $8.83▲ | $8.68 | 2 | 2 |
| Next year | $9.8▲ | $9.75 | 2 | 2 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $2.15 | $2.41 | +0.26 (+12.2%) |
| 2026-03-31 | $2.07 | $1.99 | -0.08 (-3.7%) |
| 2025-12-31 | $2 | $2.03 | +0.03 (+1.3%) |
| 2025-09-30 | $2.31 | $2.25 | -0.06 (-2.6%) |
69 ratings from 24 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| HSBC | Upgraded from Reduce | Hold | $123 $136 | Sep 10, 2026 |
| Morgan Stanley | Maintained | Overweight | $143 $170 | Mar 26, 2026 |
| Barclays | Upgraded from Underweight | Equal-Weight | — | Jan 6, 2026 |
| JP Morgan | Upgraded from Neutral | Overweight | — | Dec 8, 2025 |
| Goldman Sachs | Downgraded from Neutral | Sell | $119 $118 | Sep 12, 2025 |
| UBS | Downgraded from Buy | Neutral | — | Feb 13, 2025 |
| Erste Group | Downgraded from Buy | Hold | — | Nov 19, 2024 |
| BMO Capital | Maintained | Market Perform | $118 $120 | Oct 30, 2024 |
| B of A Securities | Downgraded from Buy | Neutral | $135 $130 | Sep 11, 2024 |
| Goldman Sachs | Downgraded from Buy | Neutral | $119 $121 | Sep 5, 2024 |
| Jefferies | Downgraded from Buy | Hold | — | Sep 3, 2024 |
| Jefferies | Maintained | Buy | $121 $122.5 | Jul 2, 2024 |
| BMO Capital | Maintained | Market Perform | $114 $116 | Apr 24, 2024 |
| BMO Capital | Initiated | Market Perform | $114 | Feb 23, 2024 |
| Morgan Stanley | Initiated | Equal-Weight | $114 | Jan 23, 2024 |
| Morgan Stanley | Upgraded from Underweight | Equal-Weight | — | Sep 25, 2023 |
| Wolfe Research | Downgraded from Outperform | Peer Perform | — | May 9, 2022 |
| Exane BNP Paribas | Downgraded from Outperform | Neutral | — | Dec 6, 2021 |
| Bryan Garnier | Downgraded from Buy | Neutral | — | Dec 3, 2021 |
| Deutsche Bank | Downgraded from Hold | Sell | — | Sep 20, 2021 |
| Argus Research | Downgraded from Buy | Hold | — | Mar 10, 2021 |
| Cowen & Co. | Downgraded from Outperform | Market Perform | $110 $105 | Feb 1, 2021 |
| Deutsche Bank | Initiated | Buy | — | Jan 15, 2021 |
| Morgan Stanley | Upgraded from Equal-Weight | Overweight | — | Sep 1, 2020 |
| Guggenheim | Downgraded from Buy | Neutral | — | Feb 25, 2020 |
No analyst notes on NVS yet.
Members whose judged calls on NVS have played out most reliably.
No settled calls on NVS yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice
Analyst Ratings
11 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 2 | 5 | 1 | 1 | Hold2.58 |
| 1 mo ago | 3 | 2 | 6 | 1 | 0 | Buy2.42 |
| 2 mo ago | 3 | 2 | 4 | 2 | 1 | Hold2.67 |
| 3 mo ago | 3 | 2 | 4 | 2 | 1 | Hold2.67 |